My latest Clinical Pipeline column for Nature Medicine: second generation anti-CD40L drugs for #MultipleSclerosis. A really cool story of deciphering the biology of adverse effects.

#Immunology #autoimmunedisease #drugdevelopment #monoclonalantibodies

https://www.nature.com/articles/d41591-023-00060-4